GLP-1 (glucagon-like peptide-1) receptor agonists are a class of drugs commonly used to manage type 2 diabetes and, more recently, obesity
Furthermore, uncertainty in accounting for individual patient variability, such as genetic predispositions, disease stage, or coexisting conditions, makes available drugs less effective across diverse patient populations 78
Your provider can assess whether your current regimen is optimal or whether alternative evidence-based adjustments might better address your concerns, such as dose reduction while maintaining weekly frequency, or switching to a different medication if tolerability is problematic
Breaking Down Barriers: The Rise of Telemedicine One of the most exciting developments driving this search spike is the evolution of healthcare delivery
Norn GN, Hopstadius J, Bate A
The study concluded that Semaglutide 0.5 and 1 mg, administered once weekly, are significantly more effective in weight reduction than Liraglutide 0.6 mg